These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 16984141

  • 1. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J.
    Bioconjug Chem; 2006; 17(5):1294-313. PubMed ID: 16984141
    [Abstract] [Full Text] [Related]

  • 2. Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
    Harris TD, Cheesman E, Harris AR, Sachleben R, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Silva P, Robinson S, Lazewatsky J, Rajopadhye M, Barrett J.
    Bioconjug Chem; 2007; 18(4):1266-79. PubMed ID: 17579472
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P, Knight LC, Welch MJ.
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
    Harris TD, Kalogeropoulos S, Nguyen T, Liu S, Bartis J, Ellars C, Edwards S, Onthank D, Silva P, Yalamanchili P, Robinson S, Lazewatsky J, Barrett J, Bozarth J.
    Cancer Biother Radiopharm; 2003 Aug; 18(4):627-41. PubMed ID: 14503959
    [Abstract] [Full Text] [Related]

  • 5. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 Aug; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 6. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC.
    Cancer Res; 2002 Nov 01; 62(21):6146-51. PubMed ID: 12414640
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Volkert WA.
    Bioconjug Chem; 2004 Nov 01; 15(4):872-80. PubMed ID: 15264876
    [Abstract] [Full Text] [Related]

  • 8. 90Y and 111In complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent.
    Onthank DC, Liu S, Silva PJ, Barrett JA, Harris TD, Robinson SP, Edwards DS.
    Bioconjug Chem; 2004 Nov 01; 15(2):235-41. PubMed ID: 15025518
    [Abstract] [Full Text] [Related]

  • 9. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M, Ogawa K, Washiyama K, Shikano N, Mori H, Amano R, Kawai K.
    Int J Cancer; 2008 Aug 01; 123(3):709-15. PubMed ID: 18498129
    [Abstract] [Full Text] [Related]

  • 10. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.
    Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, Liu S, Wang F.
    Bioconjug Chem; 2006 Aug 01; 17(4):1069-76. PubMed ID: 16848417
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE, Pearson DA, Wilson DM, Nelson CA, Guaraldi M, Azure MT, Lister-James J, Dinkelborg LM, Dean RT.
    J Med Chem; 2007 Mar 22; 50(6):1354-64. PubMed ID: 17315859
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
    Broekema M, van Eerd JJ, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC, Harris TD.
    J Med Chem; 2005 Oct 06; 48(20):6442-53. PubMed ID: 16190770
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.
    J Nucl Med; 2008 May 06; 49(5):788-95. PubMed ID: 18413403
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
    Qi CM, Guo XF, Zhang HB, Li B, Jin W, Dai M.
    Yao Xue Xue Bao; 2002 Jul 06; 37(7):522-6. PubMed ID: 12914321
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
    Vanderheyden JL, Liu G, He J, Patel B, Tait JF, Hnatowich DJ.
    Nucl Med Biol; 2006 Jan 06; 33(1):135-44. PubMed ID: 16459269
    [Abstract] [Full Text] [Related]

  • 16. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
    Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Pili R, Pomper M, Carducci M, Wagner HN.
    Bioconjug Chem; 2004 Jan 06; 15(6):1416-23. PubMed ID: 15546210
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
    Miao Y, Whitener D, Feng W, Owen NK, Chen J, Quinn TP.
    Bioconjug Chem; 2003 Jan 06; 14(6):1177-84. PubMed ID: 14624632
    [Abstract] [Full Text] [Related]

  • 18. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C, Schubiger PA, Schibli R.
    Nucl Med Biol; 2007 Aug 06; 34(6):595-601. PubMed ID: 17707798
    [Abstract] [Full Text] [Related]

  • 19. From symmetrical to asymmetrical nitrido phosphino-thiol complexes: a new class of neutral mixed-ligand (99m)Tc compounds as potential brain imaging agents.
    Bolzati C, Benini E, Cavazza-Ceccato M, Cazzola E, Malago E, Agostini S, Tisato F, Refosco F, Bandoli G.
    Bioconjug Chem; 2006 Aug 06; 17(2):419-28. PubMed ID: 16536474
    [Abstract] [Full Text] [Related]

  • 20. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
    Arosio D, Manzoni L, Araldi EM, Caprini A, Monferini E, Scolastico C.
    Bioconjug Chem; 2009 Aug 19; 20(8):1611-7. PubMed ID: 21141806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.